Guest guest Posted January 9, 2009 Report Share Posted January 9, 2009 http://www3.interscience.wiley.com/journal/121524286/abstract?CRETRY=1 & SRETRY=0 Alimentary Pharmacology & Therapeutics Volume 29 Issue 4, Pages 409 - 415 Published Online: 19 Nov 2008 2006 The Authors Journal compilation 2006 Blackwell Publishing Ltd The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B V. MALLET*,†,‡,1, V. DHALLUIN-VENIER*,†,1, C. ROUSSIN§, M. BOURLIERE¶, M. E. PETTINELLI**, C. GIRY**, A. VALLET-PICHARD*,†,‡, H. FONTAINE†,‡ & S. POL*,†,‡ *Université Paris Descartes, Paris, France ; †Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Hépatologie, Paris, France ; ‡INSERM U. 567, Paris, France ; §Centre Hospitalier de Mayotte, Unité de Médecine, Mayotte, France ; ¶Hôpital Saint ph, Hépato-gastroentérologie, Marseilles, France ; **Centre Hospitalier de Mayotte, Laboratoire de Biologie, Mayotte, France Correspondence to Dr V. Mallet, Hépatologie, Hôpital Cochin, 27 rue du faubourg Saint Jacques, 75014 Paris, France. E-mail: vincent.mallet@... 1 Contributed equally to this work. ABSTRACT Background The Fib-4 index is a simple and inexpensive biomarker to delineate liver fibrosis in chronic hepatitis C. Aim To assess the accuracy of the FIB-4 index in chronic hepatitis B. Methods We compared the FIB-4 index with 138 synchronous liver biopsies and with 372 synchronous FibroTest performed either in France or in an endemic area (Mayotte, an overseas collectivity of France). Results The FIB-4 index allowed the correct identification of patients with nil-to-moderate fibrosis with an area under the receiving operating characteristic curve of 0.81 (P < 0.001), increasing as a function of the length of the liver biopsy (up to 0.94 for liver biopsies ≥20 mm). A cut-off value ≤1.45 differentiated moderate fibrosis from severe fibrosis with a negative predictive value of 86%, a sensitivity of 71.1% and a specificity of 73.1%. Beyond 1.45, the FIB-4 index was not informative. The FIB-4 index was more precise than the AST-to-platelet ratio index and correlated with the FibroTest in 89% of the cases (κ = 0.27, P < 0.001) to exclude severe fibrosis. Conclusion The FIB-4 index is a simple, accurate and inexpensive method to exclude significant liver fibrosis in chronic hepatitis B, a major advantage in HBV-endemic developing countries. -------------------------------------------------------------------------------- Publication data Submitted 5 May 2008 First decision 21 May 2008 Resubmitted 30 September 2008 Accepted 11 November 2008 Epub Accepted Article 19 November 2008 DIGITAL OBJECT IDENTIFIER (DOI) 10.1111/j.1365-2036.2008.03895.x Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 9, 2009 Report Share Posted January 9, 2009 http://www3.interscience.wiley.com/journal/121524286/abstract?CRETRY=1 & SRETRY=0 Alimentary Pharmacology & Therapeutics Volume 29 Issue 4, Pages 409 - 415 Published Online: 19 Nov 2008 2006 The Authors Journal compilation 2006 Blackwell Publishing Ltd The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B V. MALLET*,†,‡,1, V. DHALLUIN-VENIER*,†,1, C. ROUSSIN§, M. BOURLIERE¶, M. E. PETTINELLI**, C. GIRY**, A. VALLET-PICHARD*,†,‡, H. FONTAINE†,‡ & S. POL*,†,‡ *Université Paris Descartes, Paris, France ; †Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Hépatologie, Paris, France ; ‡INSERM U. 567, Paris, France ; §Centre Hospitalier de Mayotte, Unité de Médecine, Mayotte, France ; ¶Hôpital Saint ph, Hépato-gastroentérologie, Marseilles, France ; **Centre Hospitalier de Mayotte, Laboratoire de Biologie, Mayotte, France Correspondence to Dr V. Mallet, Hépatologie, Hôpital Cochin, 27 rue du faubourg Saint Jacques, 75014 Paris, France. E-mail: vincent.mallet@... 1 Contributed equally to this work. ABSTRACT Background The Fib-4 index is a simple and inexpensive biomarker to delineate liver fibrosis in chronic hepatitis C. Aim To assess the accuracy of the FIB-4 index in chronic hepatitis B. Methods We compared the FIB-4 index with 138 synchronous liver biopsies and with 372 synchronous FibroTest performed either in France or in an endemic area (Mayotte, an overseas collectivity of France). Results The FIB-4 index allowed the correct identification of patients with nil-to-moderate fibrosis with an area under the receiving operating characteristic curve of 0.81 (P < 0.001), increasing as a function of the length of the liver biopsy (up to 0.94 for liver biopsies ≥20 mm). A cut-off value ≤1.45 differentiated moderate fibrosis from severe fibrosis with a negative predictive value of 86%, a sensitivity of 71.1% and a specificity of 73.1%. Beyond 1.45, the FIB-4 index was not informative. The FIB-4 index was more precise than the AST-to-platelet ratio index and correlated with the FibroTest in 89% of the cases (κ = 0.27, P < 0.001) to exclude severe fibrosis. Conclusion The FIB-4 index is a simple, accurate and inexpensive method to exclude significant liver fibrosis in chronic hepatitis B, a major advantage in HBV-endemic developing countries. -------------------------------------------------------------------------------- Publication data Submitted 5 May 2008 First decision 21 May 2008 Resubmitted 30 September 2008 Accepted 11 November 2008 Epub Accepted Article 19 November 2008 DIGITAL OBJECT IDENTIFIER (DOI) 10.1111/j.1365-2036.2008.03895.x Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.